Logo: Askel Healthcare: WhiteLogo: Askel Healthcare: White
  • Home
  • Company
    • About
    • Management
    • Careers
    • News
    • Events
    • For Media
  • Products
  • Professionals
    • Healthcare professionals
    • Clinical Advisory Board (CAB)
    • Research
  • Patients
  • Investors
    • Investors
    • Investor news
  • Contact
Niina
8 posts

Access to Askel Healthcare’s investor event recording

Askel Healthcare has appointed globally renowned orthopedic surgeons and sports medicine specialists to its new Clinical Advisory Board to drive change in the treatment of knee cartilage repair

Virpi & Anne-Marie

Invitation to Askel Healthcare investor event on 24 May at 16:00 EEST

Askel Healthcare to raise 5 million euros for clinical research of its COPLA® -implant to treat knee pain caused by cartilage damage

Askel Healthcare’s COPLA® implant on EVT, the national public television network of Estonia

First knee cartilage implant tested on Estonian can save people from knee pain

Askel Healthcare has reached an important milestone towards marketing authorization of the COPLA® implant in EU and the USA

First research patient operated in Estonia with Askel Healthcare’s COPLA® knee cartilage repair implant

Home
About
Management
Careers
News
Events
For media
Products
Professionals
Clinical Advisory Board (CAB)
Research
Patients
Investors
Investor news
Contact

Privacy notice
Cookie declaration

Askel Healthcare Ltd (Headquarters)
Siltasaarenkatu 8-10
00530 Helsinki
Finland

Askel Healthcare Ltd
Naulakatu 3
33100 Tampere
Finland

Get in touch
info@askelhealthcare.com
+358 40 489 3840

Co-funded by the European Union
Tissue Cure